Geode Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Geode Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,326	Closed	-$21.6K	–	4705
2023 Q3	$21.6K	Buy	4,326 +1,857	+75%	+$11.5K	﹤0.01%	4614
2023 Q2	$17.2K	Hold	2,469	–	–	﹤0.01%	4675
2023 Q1	$23.5K	Sell	2,469 -49	-2%	-$515	﹤0.01%	4672
2022 Q4	$15K	Hold	2,518	–	–	﹤0.01%	4803
2022 Q3	$34K	Hold	2,518	–	–	﹤0.01%	4833
2022 Q2	$101K	Sell	2,518 -4,915	-66%	-$304K	﹤0.01%	4588
2022 Q1	$782K	Sell	7,433 -405	-5%	-$29.7K	﹤0.01%	3721
2021 Q4	$903K	Sell	7,838 -659	-8%	-$158K	﹤0.01%	3767
2021 Q3	$3.22M	Buy	8,497 +3,964	+87%	+$1.33M	﹤0.01%	3156
2021 Q2	$1.85M	Buy	4,533 +454	+11%	+$209K	﹤0.01%	3301
2021 Q1	$1.95M	Buy	+4,079	New	+$2.22M	﹤0.01%	3261

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management's NEXI Position: Q4 2023 in Review

Geode Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 4,326 shares — an estimated $21.6K sold.

Geode Capital Management first reported a position in NEXI in Q1 2021 and held it in 11 quarters. The position peaked at $3.22M in Q3 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Geode Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Geode Capital Management sold 4,326 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $21.6K.
Geode Capital Management first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Geode Capital Management's NexImmune, Inc. Common Stock position peaked at $3.22M in Q3 2021.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.